Cargando…
Alterations in the gut microbiome and metabolome profiles of septic mice treated with Shen FuHuang formula
Sepsis has a high mortality rate, and treating sepsis remains a significant challenge worldwide. In former studies, our group found that traditional Chinese medicine, Shen FuHuang formula (SFH), is a promising medicine in treating coronavirus disease 2019 (COVID-19) patients with the septic syndrome...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030955/ https://www.ncbi.nlm.nih.gov/pubmed/36970673 http://dx.doi.org/10.3389/fmicb.2023.1111962 |
_version_ | 1784910491808694272 |
---|---|
author | He, Shasha Zhao, Chunxia Guo, Yuhong Zhao, Jingxia Xu, Xiaolong Hu, Yahui Lian, Bo Ye, Haoran Wang, Ning Luo, Lianxiang Liu, Qingquan |
author_facet | He, Shasha Zhao, Chunxia Guo, Yuhong Zhao, Jingxia Xu, Xiaolong Hu, Yahui Lian, Bo Ye, Haoran Wang, Ning Luo, Lianxiang Liu, Qingquan |
author_sort | He, Shasha |
collection | PubMed |
description | Sepsis has a high mortality rate, and treating sepsis remains a significant challenge worldwide. In former studies, our group found that traditional Chinese medicine, Shen FuHuang formula (SFH), is a promising medicine in treating coronavirus disease 2019 (COVID-19) patients with the septic syndrome. However, the underlying mechanisms remain elusive. In the present study, we first investigated the therapeutic effects of SFH on septic mice. To investigate the mechanisms of SFH-treated sepsis, we identified the gut microbiome profile and exploited untargeted metabolomics analyses. The results demonstrated that SFH significantly enhanced the mice’s 7-day survival rate and hindered the release of inflammatory mediators, i.e., TNF-α, IL-6, and IL-1β. 16S rDNA sequencing further deciphered that SFH decreased the proportion of Campylobacterota and Proteobacteria at the phylum level. LEfSe analysis revealed that the treatment of SFH enriched Blautia while decreased Escherichia_Shigella. Furthermore, serum untargeted metabolomics analysis indicated that SFH could regulate the glucagon signaling pathway, PPAR signaling pathway, galactose metabolism, and pyrimidine metabolism. Finally, we found the relative abundance of Bacteroides, Lachnospiraceae_NK4A136_group, Escherichia_Shigella, Blautia, Ruminococcus, and Prevotella were closely related to the enrichment of the metabolic signaling pathways, including L-tryptophan, uracil, glucuronic acid, protocatechuic acid, and gamma-Glutamylcysteine. In conclusion, our study demonstrated that SFH alleviated sepsis by suppressing the inflammatory response and hence reduced mortality. The mechanism of SFH for treating sepsis may be ascribed to the enrichment of beneficial gut flora and modulation in glucagon signaling pathway, PPAR signaling pathway, galactose metabolism, and pyrimidine metabolism. To sum up, these findings provide a new scientific perspective for the clinical application of SFH in treating sepsis. |
format | Online Article Text |
id | pubmed-10030955 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100309552023-03-23 Alterations in the gut microbiome and metabolome profiles of septic mice treated with Shen FuHuang formula He, Shasha Zhao, Chunxia Guo, Yuhong Zhao, Jingxia Xu, Xiaolong Hu, Yahui Lian, Bo Ye, Haoran Wang, Ning Luo, Lianxiang Liu, Qingquan Front Microbiol Microbiology Sepsis has a high mortality rate, and treating sepsis remains a significant challenge worldwide. In former studies, our group found that traditional Chinese medicine, Shen FuHuang formula (SFH), is a promising medicine in treating coronavirus disease 2019 (COVID-19) patients with the septic syndrome. However, the underlying mechanisms remain elusive. In the present study, we first investigated the therapeutic effects of SFH on septic mice. To investigate the mechanisms of SFH-treated sepsis, we identified the gut microbiome profile and exploited untargeted metabolomics analyses. The results demonstrated that SFH significantly enhanced the mice’s 7-day survival rate and hindered the release of inflammatory mediators, i.e., TNF-α, IL-6, and IL-1β. 16S rDNA sequencing further deciphered that SFH decreased the proportion of Campylobacterota and Proteobacteria at the phylum level. LEfSe analysis revealed that the treatment of SFH enriched Blautia while decreased Escherichia_Shigella. Furthermore, serum untargeted metabolomics analysis indicated that SFH could regulate the glucagon signaling pathway, PPAR signaling pathway, galactose metabolism, and pyrimidine metabolism. Finally, we found the relative abundance of Bacteroides, Lachnospiraceae_NK4A136_group, Escherichia_Shigella, Blautia, Ruminococcus, and Prevotella were closely related to the enrichment of the metabolic signaling pathways, including L-tryptophan, uracil, glucuronic acid, protocatechuic acid, and gamma-Glutamylcysteine. In conclusion, our study demonstrated that SFH alleviated sepsis by suppressing the inflammatory response and hence reduced mortality. The mechanism of SFH for treating sepsis may be ascribed to the enrichment of beneficial gut flora and modulation in glucagon signaling pathway, PPAR signaling pathway, galactose metabolism, and pyrimidine metabolism. To sum up, these findings provide a new scientific perspective for the clinical application of SFH in treating sepsis. Frontiers Media S.A. 2023-03-08 /pmc/articles/PMC10030955/ /pubmed/36970673 http://dx.doi.org/10.3389/fmicb.2023.1111962 Text en Copyright © 2023 He, Zhao, Guo, Zhao, Xu, Hu, Lian, Ye, Wang, Luo and Liu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Microbiology He, Shasha Zhao, Chunxia Guo, Yuhong Zhao, Jingxia Xu, Xiaolong Hu, Yahui Lian, Bo Ye, Haoran Wang, Ning Luo, Lianxiang Liu, Qingquan Alterations in the gut microbiome and metabolome profiles of septic mice treated with Shen FuHuang formula |
title | Alterations in the gut microbiome and metabolome profiles of septic mice treated with Shen FuHuang formula |
title_full | Alterations in the gut microbiome and metabolome profiles of septic mice treated with Shen FuHuang formula |
title_fullStr | Alterations in the gut microbiome and metabolome profiles of septic mice treated with Shen FuHuang formula |
title_full_unstemmed | Alterations in the gut microbiome and metabolome profiles of septic mice treated with Shen FuHuang formula |
title_short | Alterations in the gut microbiome and metabolome profiles of septic mice treated with Shen FuHuang formula |
title_sort | alterations in the gut microbiome and metabolome profiles of septic mice treated with shen fuhuang formula |
topic | Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030955/ https://www.ncbi.nlm.nih.gov/pubmed/36970673 http://dx.doi.org/10.3389/fmicb.2023.1111962 |
work_keys_str_mv | AT heshasha alterationsinthegutmicrobiomeandmetabolomeprofilesofsepticmicetreatedwithshenfuhuangformula AT zhaochunxia alterationsinthegutmicrobiomeandmetabolomeprofilesofsepticmicetreatedwithshenfuhuangformula AT guoyuhong alterationsinthegutmicrobiomeandmetabolomeprofilesofsepticmicetreatedwithshenfuhuangformula AT zhaojingxia alterationsinthegutmicrobiomeandmetabolomeprofilesofsepticmicetreatedwithshenfuhuangformula AT xuxiaolong alterationsinthegutmicrobiomeandmetabolomeprofilesofsepticmicetreatedwithshenfuhuangformula AT huyahui alterationsinthegutmicrobiomeandmetabolomeprofilesofsepticmicetreatedwithshenfuhuangformula AT lianbo alterationsinthegutmicrobiomeandmetabolomeprofilesofsepticmicetreatedwithshenfuhuangformula AT yehaoran alterationsinthegutmicrobiomeandmetabolomeprofilesofsepticmicetreatedwithshenfuhuangformula AT wangning alterationsinthegutmicrobiomeandmetabolomeprofilesofsepticmicetreatedwithshenfuhuangformula AT luolianxiang alterationsinthegutmicrobiomeandmetabolomeprofilesofsepticmicetreatedwithshenfuhuangformula AT liuqingquan alterationsinthegutmicrobiomeandmetabolomeprofilesofsepticmicetreatedwithshenfuhuangformula |